Trial NCT03815682

View at ClinicalTrials.gov 
Org. Study IDs: TT-101
Secondary IDs: KEYNOTE KN-948

Last trial update was posted on 2022-12-06

MeSH Interventions

Pembrolizumab

MeSH Conditions

Lymphoma

Other Conditions

Solid Tumor

Stopping Reasons

Development program terminated

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID